Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.
BACKGROUND: Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its value in ACHD has limitations. Asymmetrical dimethylarginine (ADMA) correlat...
Main Authors: | Oktay Tutarel, Agnieszka Denecke, Stefanie M Bode-Böger, Jens Martens-Lobenhoffer, Svjetlana Lovric, Johann Bauersachs, Bernhard Schieffer, Mechthild Westhoff-Bleck, Jan T Kielstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3312350?pdf=render |
Similar Items
-
Angiopoietin-2 in adults with congenital heart disease and heart failure.
by: Alexander Lukasz, et al.
Published: (2013-01-01) -
NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
by: Susanne J. Maurer, et al.
Published: (2023-04-01) -
The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01) -
GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01) -
Using NT-proBNP as a criterion for heart failure hospitalization
by: Babak Tamizifar, et al.
Published: (2012-01-01)